AzTrials
AzTrials

Cerebral PalsyPhase 1/2NCT01086670

Physical, Functional and Neural Effects of Two Lower Extremity Exercise Protocols in Children With Cerebral Palsy

A Phase 1/2 study testing Physical Exercise in people with Cerebral Palsy and Children, run by National Institutes of Health Clinical Center (CC) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Many people who have cerebral palsy (CP) have spastic diplegia, which affects the legs and causes difficulty with leg movement and walking. Research has shown that exercise can help those with CP learn to move their arms better, but more research is needed to determine whether exercise programs can improve… Read more about this study

Who is it for?
Ages 5 to 17 years
Conditions the study is for
Cerebral Palsy, Children, Adolescents
What is being tested?
Physical Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteUnited States
Study dates
30 Mar 2010to 9 May 2016
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • For those without CP (healthy volunteers)
  • Must be between the ages of 5-17, inclusive
  • Must be in good general health
  • Must be able to understand and comply with the requirements of the study
  • For those with CP
  • Must be between the ages of 5-17, inclusive
Show all 11Show fewer
  • Have a diagnosis of spastic bilateral cerebral palsy
  • Documentation on previous MRI of peri-ventricular white matter injury
  • Able to walk at least 20 feet without stopping and without the need for assistance by another person. A hand-held assistive device (e.g. cane, walker) may be used if necessary.
  • Be able to understand and comply with the requirements of the study
  • Availability of an adult who agrees to be primarily responsible for completing the reporting requirements for the study and supervising the exercise program

Who cannot join

  • For those without CP (healthy volunteers)
  • 1. Have a history of musculoskeletal or neurological injury or disorder or general medical condition that would affect the use of the legs or limit the ability to safely perform motor testing
  • For those with CP:
  • Receiving oral or intrathecal baclofen, which may depress neural plasticity, at the time of enrollment or during the study period
  • Had surgery to the lower extremities in the past year or any major surgery within the past 6 months
  • Presence of any major medical illness that would limit the ability to safely tolerate the exercise program
Show all 17Show fewer
  • Requiring or desiring to have botulinum toxin injections within four months before or at any time during the study period.
  • Requiring the use of a device that provides support of the pelvis when walking (e.g. gait trainer)
  • If choosing to participate in the exercise program, cannot be currently using an exercise machine or start using one during the study period.
  • ADDITIONAL EXCLUSION CRITERIA FOR THOSE HAVING A MRI:
  • Pregnancy: For any female of childbearing potential who is not pregnant, a pregnancy test will be done.
  • A ventriculo-peritoneal shunt
  • Claustrophobia
  • Metal fragments, wires or implants in the brain or in any part of the skin or body
  • Excessive startle reaction to or fear of loud noises
  • Inability to remain still and quiet for up to five minutes at a time
  • Inability to be off levodopa for at least 24 hours

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: Physical, Functional and Neural Effects of Two Lower Extremity Exercise Programs in Children With Cerebral Palsy

Background:

  • Many people who have cerebral palsy (CP) have spastic diplegia, which affects the legs and causes difficulty with leg movement and walking. Research has shown that exercise can help those with CP learn to move their arms better, but more research is needed to determine whether exercise programs can improve leg movements in people with CP.
  • Walking on a treadmill with the help of a physical therapist has improved the treatment outcomes of some individuals with spinal cord injuries. Many children with CP already have physical therapy but still have trouble with walking and leg coordination. Two other kinds of exercise machines, a stationary bicycle and an elliptical machine, used in the home, may be able to help children with CP walk better and move their legs better.
Read more

Objectives:

  • To see how children with cerebral palsy (CP) move their legs differently from children without CP.
  • To see if an exercise program can improve leg coordination in children with CP.

Eligibility:

  • Children between 5 and 17 years of age who either have spastic diplegia CP or are healthy volunteers.

Design:

  • Children who are able and willing will have magnetic resonance imaging (MRI) scans at the start and the end of the study.
  • During Part I of the study, participants will demonstrate their leg and muscle function with the following tests:
  • Measurement of leg size and movement
  • Combined camera motion study and electrical impulse evaluation to assess how well the participant walks (with or without an assistive device, as needed)
  • Leg movement tests on an exercise bicycle and elliptical machine
  • Tests of leg muscle strength, stiffness, and effectiveness
  • Ultrasound scans of leg muscle
  • Parents of participants will complete computer-based questionnaires about their child s motor abilities.
  • A smaller group of participants will continue to Part II of the study, which involves regular exercise of 20 minutes a day, 5 days a week, for 3 months, on a stationary bicycle or elliptical trainer. Half of the group will start this exercise program immediately after the first part of the study, while the other half will wait 3 months before beginning the exercise program.
  • During Part II, participants will return to the clinical center for two more sets of the tests and evaluations performed in Part I.
Read the detailed description

Objectives:

Our primary objectives are to: 1) characterize and compare lower extremity motor coordination in children with cerebral palsy (CP) across mobility levels and to children without CP; and 2) evaluate the effects of two home-based exercise programs on motor coordination, as well as other physical, functional and neurological outcomes in children with CP. We hypothesize children with CP will exhibit significant coordination deficits compared to those without CP and that each exercise program will lead to significant improvements in outcomes.

Study Population:

Objective 1 will include 60 ambulatory children with spastic diplegic CP (20 in each of three mobility levels) and 20 children without CP within the same age range. Forty (40) children with CP will participate in Objective 2; 20 in each exercise group.

Design:

In Objective 1, the multiple measures taken at a single point in time will be compared across the three CP and the control groups. Children with CP from Objective 1 will be invited consecutively to participate in the exercise program (Objective 2), until enrollment is complete. Participation in Objective 2 lasts for 6 months. Subjects will be randomly assigned to use one of two novel lower extremity exercise devices: a motor-assisted cycle or an elliptical trainer. Children will exercise for 20 minutes, 5 days a week for 12 consecutive weeks. The major goal of each is to increase the ability to cycle or step at a rapid pace (the target goal is 40 RPM), with resistance added once speed goals are attained and thereafter progressed gradually. The timing of the exercise period (immediate vs. delayed for 3 months) will also be randomly assigned allowing assessors to be masked to group assignment.

Outcome Measures:

The primary outcome is the difference (Objective 1) or pre to post-exercise change (Objective 2) in coordination as measured by the fastest active (voluntary) cadence with each device. Additional coordination measures include cadence at free speed, variability in cadence, and EMG reciprocation vs. synchronization. Selective Control Assessment for the Lower extremity (SCALE), strength and spasticity tests and ultrasound measures of muscle size will be assessed at each time point. These will be compared across groups and before and after the two exercise programs. Functional outcomes include gait speed and two validated computer-based questionnaires. Neural outcomes include selected measures of gray and white matter connectivity as assessed with fcMRI and DTI, respectively.

Being tested
Physical Exercise
Keywords
Coordination, Neuroimaging, Motion Analysis, Locomotor
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical ExerciseOther

    Children will be assigned either an elliptical machine or cycle to take home. Each exercise will be performed for 20 minutes per day, 5 days per week for a period of 12 consecutive weeks, or 60 sessions in all. To avoid excessive fatigue or over-training effects, children are asked to adhere to this exact schedule and not to exercise more than this. Children are asked to complete as many of the sessions as they can. To allow for sick days or vacation during the program, the duration of the training can be extended up to 2 more weeks if needed to try to complete all 60 sessions. Compliance (percent sessions completed) will be correlated with outcomes in the statistical analyses.

Study groups in NCT01086670
Study groupRoleWhat they receive
1OtherSubjects will be randomly assigned to use one of two novel lower extremity exercise devices: a motor-assisted cycle or an elliptical trainer.
Receives: Other: Physical Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Coordination as measured by fast cadence during device and walking

    Cadence is the number of device cycles or gait cycles performed in a minute.

    Measured: per test, 3 months post test, 3 months follow up

Secondary outcomes (1)
  1. 3D Motion Capture of walking, cycling and elliptical, Surface electromyography, Selective Control Assessment of Lower Extremities, Physical examination, Muscle Ultrasound. strength and spasticity, Questionnaires, Magnetic Resonance Imaging

    Tests will be presented in the same order at each assessment, with the 3D motion assessments of the cycling and steppingperformed first since these involve collection of the primary outcome measure, cadence.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2010 (estimated)
  2. Study start30 Mar 2010
  3. Primary completion12 Jan 2015
  4. Study completion9 May 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01086670
Sponsor's protocol ID
100073
Other IDs
10-CC-0073
Status last verified
Mar 2022
First submitted
12 Mar 2010
Last updated
29 Mar 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Physical Exercise in people with Cerebral Palsy and Children, run by National Institutes of Health Clinical Center (CC) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Coordination as measured by fast cadence during device and walking (time frame: per test, 3 months post test, 3 months follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in